AIM – aim immunotech inc. (US:NASDAQ)
Stock Stats
News
AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors [Yahoo! Finance]
AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors
AIM ImmunoTech Announces Closing of its Rights Offering [Yahoo! Finance]
AIM ImmunoTech Announces Closing of its Rights Offering
AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million [Yahoo! Finance]
Form 10-K AIM ImmunoTech Inc. For: Dec 31
Form 4 AIM ImmunoTech Inc. For: Mar 16 Filed by: CHEMEROW DAVID I.
Form 4 AIM ImmunoTech Inc. For: Mar 16 Filed by: Equels Thomas K
Form 4 AIM ImmunoTech Inc. For: Mar 06 Filed by: CHEMEROW DAVID I.
Form 4 AIM ImmunoTech Inc. For: Mar 06 Filed by: Equels Thomas K
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.